NCT01949038View on ClinicalTrials.gov

Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

January 31, 2013

Conditions
Diagnostic Esophagogastroduodenoscopy
Interventions
DRUG

Oral alprazolam

DRUG

Sublingual alprazolam

DRUG

Oral placebo

DRUG

Sublingual placebo

Trial Locations (1)

Unknown

Private Outpatient Clinic of Gastroenterology, Isfahan

All Listed Sponsors
lead

Isfahan University of Medical Sciences

OTHER

NCT01949038 - Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy | Biotech Hunter | Biotech Hunter